Genentech, a Member of the Roche Group
Tuesday, June 04, 2024
Company Presentation
Multiple Therapeutics
Company Presentation Theater 2
Genentech pioneered the biotech industry and revolutionized how we treat some of the world’s most complex health problems. Today, as a member of the Roche Group, we remain dedicated to pursuing breakthrough research, developing life-changing medicines, unlocking advances in data and technology, and partnering across society to take on systemic issues that stand in the way of better healthcare for all.
We lead change in our industry and advance science for the greater good. We embrace diversity and inclusion to drive innovation, improve outcomes, and create more equitable healthcare access. And every day, we lean into the biggest challenges in science, medicine, technology, and beyond to deliver patient-centered healthcare that improves life for every person.
Company Website:
http://gene.com
Lead Product in Development:
Ocrevus
Exchange
SIX Swiss Exchange
Ticker
RHHBY
Company HQ City
South San Francisco
Company HQ State
California
Company HQ Country
United States
CEO/Top Company Official
Ashley Magargee
Development Phase of Primary Product
Multiple Products in Market
Primary Speaker
Executive Director, Immunology, Infectious Disease, Cardiovascular/Metabolism, Pharma Partnering
Genentech